Dynamics and plasticity of the epithelial to mesenchymal transition induced by miR-200 family inhibition

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Haraguchi, Takeshi ^a   Kondo, Masayuki ^a   Uchikawa, Ryo ^a   Kobayashi, Kazuyoshi ^a   Hiramatsu, Hiroaki ^a   Kobayashi, Kyousuke ^a   Chit, Ung Weng ^a   Shimizu, Takanobu ^a   Iba, Hideo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN200 MICRORNA, HUMAN;

ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC EPIGENESIS; GENETICS; HUMAN; TUMOR CELL LINE;

CELL LINE, TUMOR; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MICRORNAS;

EID: 84959121523     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21117     Document Type: Article

References (29)

1. Savagner, P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23, 912-923, doi: 10.1002/bies.1132 (2001).
2. Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315, 1650-1659, doi: 10.1056/NEJM198612253152606 (1986).
3. Park, S. M., Gaur, A. B., Lengyel, E. & Peter, M. E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22, 894-907, doi: 10.1101/gad.1640608 (2008).
4. Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10, 593-601, doi: 10.1038/ncb1722 (2008).
5. Ding, W. et al. miR-200b restoration and DNA methyltransferase inhibitor block lung metastasis of mesenchymal-phenotype hepatocellular carcinoma. Oncogenesis 1, e15, doi: 10.1038/oncsis.2012.15 (2012).
6. Jurmeister, S. et al. MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F. Mol Cell Biol 32, 633-651, doi: 10.1128/MCB.06212-11 (2012).
7. Howe, E. N., Cochrane, D. R. & Richer, J. K. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res 13, R45, doi: 10.1186/bcr2867 (2011).
8. Liu, Y. N. et al. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene 32, 296-306, doi: 10.1038/onc.2012.58 (2013).
9. Shimono, Y. et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592-603, doi: 10.1016/j.cell.2009.07.011 (2009).
10. Bracken, C. P. et al. Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion. EMBO J 33, 2040-2056, doi: 10.15252/embj.201488641 (2014).
11. Burk, U. et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9, 582-589, doi: 10.1038/embor.2008.74 (2008).
12. Bindels, S. et al. Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 25, 4975-4985, doi: 10.1038/ sj.onc.1209511 (2006).
13. Gemmill, R. M. et al. ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett 300, 66-78, doi: 10.1016/j.canlet.2010.09.007 (2011).
14. Eger, A. et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24, 2375-2385, doi: 10.1038/sj.onc.1208429 (2005).
15. Vannier, C., Mock, K., Brabletz, T. & Driever, W. Zeb1 regulates E-cadherin and Epcam (epithelial cell adhesion molecule) expression to control cell behavior in early zebrafish development. J Biol Chem 288, 18643-18659, doi: 10.1074/jbc.M113.467787 (2013).
16. Horiguchi, K. et al. TGF-β drives epithelial-mesenchymal transition through d EF1-mediated downregulation of ESRP. Oncogene 31, 3190-3201, doi: 10.1038/onc.2011.493 (2012).
17. Haraguchi, T., Ozaki, Y. & Iba, H. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res 37, e43, doi: 10.1093/nar/gkp040 (2009).
18. Bak, R. O., Hollensen, A. K., Primo, M. N., Sorensen, C. D. & Mikkelsen, J. G. Potent microRNA suppression by RNA Pol IItranscribed 'Tough Decoy' inhibitors. RNA 19, 280-293, doi: 10.1261/rna.034850.112 (2013).
19. Xie, J. et al. Long-term, efficient inhibition of microRNA function in mice using rAAV vectors. Nat Methods 9, 403-409, doi: 10.1038/nmeth.1903 (2012).
20. Haraguchi, T. et al. A potent 2'-O-methylated RNA-based microRNA inhibitor with unique secondary structures. Nucleic Acids Res 40, e58, doi: 10.1093/nar/gkr1317 (2012).
21. Murphy, S., Pierani, A., Scheidereit, C., Melli, M. & Roeder, R. G. Purified octamer binding transcription factors stimulate RNA polymerase III-mediated transcription of the 7SK RNA gene. Cell 59, 1071-1080 (1989).
22. Boyd, D. C., Turner, P. C., Watkins, N. J., Gerster, T. & Murphy, S. Functional redundancy of promoter elements ensures efficient transcription of the human 7SK gene in vivo. J Mol Biol 253, 677-690, doi: 10.1006/jmbi.1995.0582 (1995).
23. Bertrand, K. P., Postle, K., Wray, L. V. & Reznikoff, W. S. Overlapping divergent promoters control expression of Tn10 tetracycline resistance. Gene 23, 149-156 (1983).
24. Hillen, W. & Schollmeier, K. Nucleotide sequence of the Tn10 encoded tetracycline resistance gene. Nucleic Acids Res 11, 525-539 (1983).
25. Warzecha, C. C., Sato, T. K., Nabet, B., Hogenesch, J. B. & Carstens, R. P. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell 33, 591-601, doi: 10.1016/j.molcel.2009.01.025 (2009).
26. Marjanovic, N. D. & Weinberg, R. A. & Chaffer, C. L. Poised with purpose: cell plasticity enhances tumorigenicity. Cell Cycle 12, 2713-2714, doi: 10.4161/cc.26075 (2013).
27. Gupta, P. B. et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146, 633-644, doi: 10.1016/j.cell.2011.07.026 (2011).
28. Hollensen, A. K., Bak, R. O., Haslund, D. & Mikkelsen, J. G. Suppression of microRNAs by dual-targeting and clustered Tough Decoy inhibitors. RNA Biol 10, 406-414, doi: 10.4161/rna.23543 (2013).
29. Lian, X. et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci USA 109, E1848-1857, doi: 10.1073/pnas.1200250109 (2012).